Evaluation of Time-Dependent Cytochrome P450 Inhibition Using the Area Under the Curve Shift Method

Author(s):  
Julie Huang
2012 ◽  
Vol 6 (1) ◽  
pp. 43-53 ◽  
Author(s):  
Sophie Mukadam ◽  
Suzanne Tay ◽  
Daniel Tran ◽  
Leslie Wang ◽  
Erlie M. Delarosa ◽  
...  

1998 ◽  
Vol 151 (2) ◽  
pp. 294-310 ◽  
Author(s):  
Michael J. Santostefano ◽  
Xiaofeng Wang ◽  
Vicki M. Richardson ◽  
David G. Ross ◽  
Michael J. DeVito ◽  
...  

2012 ◽  
Vol 40 (12) ◽  
pp. 2289-2296 ◽  
Author(s):  
Phillip Yates ◽  
Heather Eng ◽  
Li Di ◽  
R. Scott Obach

2015 ◽  
Vol 22 (21) ◽  
pp. 16319-16328 ◽  
Author(s):  
Jennifer Bräunig ◽  
Sabrina Schiwy ◽  
Oliver Broedel ◽  
Yvonne Müller ◽  
Marcus Frohme ◽  
...  

Xenobiotica ◽  
2013 ◽  
Vol 43 (9) ◽  
pp. 765-773 ◽  
Author(s):  
Kazunori Iwanaga ◽  
Tatsuya Honjo ◽  
Makoto Miyazaki ◽  
Masawo Kakemi

2010 ◽  
Vol 54 (7) ◽  
pp. 2840-2846 ◽  
Author(s):  
Venkata M. Reddy ◽  
Leo Einck ◽  
K. Andries ◽  
Carol A. Nacy

ABSTRACT The in vitro interactions of two new antitubercular drugs, SQ109 and TMC207, with each other and with rifampin (RIF) were evaluated. The combination of SQ109 with TMC207 (i) improved an already excellent TMC207 MIC for M. tuberculosis H37Rv by 4- to 8-fold, (ii) improved the rate of killing of bacteria over the rate of killing by each single drug, and (iii) enhanced the drug postantibiotic effect by 4 h. In no instance did we observe antagonistic activities with the combination of SQ109 and TMC207. Rifampin activates cytochrome P450 genes to reduce the area under the curve (AUC) for TMC207 in humans. The presence of RIF in three-drug combinations did not affect the synergistic activities of SQ109 and TMC207, and SQ109 also dramatically decreased the MIC of RIF. SQ109 was active by itself, and both its activity was improved by and it improved the in vitro activities of both RIF and TMC207.


Sign in / Sign up

Export Citation Format

Share Document